CA2064091A1 - Diagnostic de l'hyperthermie maligne chez le porc - Google Patents

Diagnostic de l'hyperthermie maligne chez le porc

Info

Publication number
CA2064091A1
CA2064091A1 CA2064091A CA2064091A CA2064091A1 CA 2064091 A1 CA2064091 A1 CA 2064091A1 CA 2064091 A CA2064091 A CA 2064091A CA 2064091 A CA2064091 A CA 2064091A CA 2064091 A1 CA2064091 A1 CA 2064091A1
Authority
CA
Canada
Prior art keywords
pct
diagnosis
malignant hyperthermia
sec
approximately
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2064091A
Other languages
English (en)
Other versions
CA2064091C (fr
Inventor
David H. Maclennan
Peter J. O'brien
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Guelph
University of Toronto
Original Assignee
University of Toronto Innovations Foundation
University of Guelph
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27265419&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2064091(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB909027869A external-priority patent/GB9027869D0/en
Priority claimed from GB919110865A external-priority patent/GB9110865D0/en
Priority claimed from GB919119250A external-priority patent/GB9119250D0/en
Application filed by University of Toronto Innovations Foundation, University of Guelph filed Critical University of Toronto Innovations Foundation
Priority to CA002079702A priority Critical patent/CA2079702A1/fr
Publication of CA2064091A1 publication Critical patent/CA2064091A1/fr
Application granted granted Critical
Publication of CA2064091C publication Critical patent/CA2064091C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/40—Disorders due to exposure to physical agents, e.g. heat disorders, motion sickness, radiation injuries, altitude sickness, decompression illness

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Radiation-Therapy Devices (AREA)
  • Finger-Pressure Massage (AREA)
  • Electrotherapy Devices (AREA)
  • Thermotherapy And Cooling Therapy Devices (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA002064091A 1990-12-21 1991-12-20 Diagnostic de l'hyperthermie maligne chez le porc Expired - Lifetime CA2064091C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002079702A CA2079702A1 (fr) 1990-12-21 1991-12-20 Diagnostic de l'hyperthermie maligne du porc

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB9027869.8 1990-12-21
GB909027869A GB9027869D0 (en) 1990-12-21 1990-12-21 Diagnosis for porcine malignant hyperthermia
GB9110865.4 1991-05-20
GB919110865A GB9110865D0 (en) 1991-05-20 1991-05-20 Diagnosis for porcine malignant hyperthermia
GB9119250.0 1991-09-09
GB919119250A GB9119250D0 (en) 1991-09-09 1991-09-09 Diagnosis of porcine malignant hyperthermia

Publications (2)

Publication Number Publication Date
CA2064091A1 true CA2064091A1 (fr) 1992-06-22
CA2064091C CA2064091C (fr) 1993-03-16

Family

ID=27265419

Family Applications (2)

Application Number Title Priority Date Filing Date
CA002064091A Expired - Lifetime CA2064091C (fr) 1990-12-21 1991-12-20 Diagnostic de l'hyperthermie maligne chez le porc
CA002079702A Abandoned CA2079702A1 (fr) 1990-12-21 1991-12-20 Diagnostic de l'hyperthermie maligne du porc

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA002079702A Abandoned CA2079702A1 (fr) 1990-12-21 1991-12-20 Diagnostic de l'hyperthermie maligne du porc

Country Status (12)

Country Link
US (1) US5358649A (fr)
EP (1) EP0563144B2 (fr)
AT (1) ATE120488T1 (fr)
AU (1) AU665178B2 (fr)
CA (2) CA2064091C (fr)
DE (2) DE563144T1 (fr)
DK (1) DK0563144T4 (fr)
ES (1) ES2072749T5 (fr)
IE (1) IE67816B1 (fr)
NZ (1) NZ241112A (fr)
WO (1) WO1992011387A1 (fr)
ZA (1) ZA9110087B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5668006A (en) * 1992-07-17 1997-09-16 American Cyanamid Company Somatostatin receptors
GB9503808D0 (en) * 1995-02-24 1995-04-12 Univ Nottingham Detection assay
GB2333154B (en) * 1996-10-07 2001-05-09 Meat And Livestock Commission Assay for duroc muscle fibre tyre
EP0929814A1 (fr) * 1996-10-07 1999-07-21 Meat And Livestock Commission Methode de selection de fibres musculaires de type duroc
US6355859B1 (en) 1997-05-20 2002-03-12 Biotechnology Research And Development Corporation Interactions between genotype and diet in swine that prevent E. coli associated intestinal disease
HK1040097A1 (zh) 1997-05-20 2002-05-24 生物技术研究及发展公司 鑒定f18大腸杆菌相關疾病遺傳抗性猪的方法和組合物
US6306591B1 (en) 1997-06-18 2001-10-23 Utah State University Screening for the molecular defect causing spider lamb syndrome in sheep
EP1026244A1 (fr) * 1999-02-03 2000-08-09 Europäisches Laboratorium Für Molekularbiologie (Embl) Protéines capables d'induire la transition G2/M et d'interagir avec la CDC2 et la Cycline B
NO314277B1 (no) * 1999-06-08 2003-02-24 Unifob Stiftelsen Universitets Deteksjon av ryanodin-reseptor-antistoff
EP1781784A2 (fr) * 2004-08-02 2007-05-09 BASF Plant Science GmbH Procede pour l'isolement de sequences de terminaison de transcription

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341094C (fr) * 1989-09-25 2000-09-05 Ronald G. Worton Diagnostic de l'hyperthermie maligne

Also Published As

Publication number Publication date
DK0563144T4 (da) 2003-03-31
IE914495A1 (en) 1992-07-01
CA2064091C (fr) 1993-03-16
AU9103891A (en) 1992-07-22
EP0563144B2 (fr) 2003-02-19
ZA9110087B (en) 1992-10-28
DE69108568D1 (de) 1995-05-04
IE67816B1 (en) 1996-05-01
DE69108568T3 (de) 2004-03-04
CA2079702A1 (fr) 1992-06-22
ES2072749T5 (es) 2003-11-16
WO1992011387A1 (fr) 1992-07-09
ATE120488T1 (de) 1995-04-15
AU665178B2 (en) 1995-12-21
ES2072749T3 (es) 1995-07-16
DE563144T1 (de) 1994-02-03
US5358649A (en) 1994-10-25
DE69108568T2 (de) 1995-12-14
EP0563144B1 (fr) 1995-03-29
NZ241112A (en) 1993-09-27
DK0563144T3 (da) 1995-08-28
EP0563144A1 (fr) 1993-10-06

Similar Documents

Publication Publication Date Title
AU8635391A (en) Nucleotide sequences coding for a human protein with angiogenesis regulative properties
AU594488B2 (en) Agents for the treatment of arthroses
IL125124A0 (en) Dimeric forms of the protein fapalpha and uses thereof
AU2001290837A1 (en) Use of a polypeptide comprising the extracellular domains of il-20rb for the treatment of inflammation
NZ335485A (en) Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof
AUPP051497A0 (en) Antimicrobial peptides
DK0728148T3 (da) Forbedrede immunogene sammensætninger mod humant gastrin 17
EP0259160A3 (fr) Gènes synthétiques pour l'alpha-interleukine-1 humaine
AU3146597A (en) Non-nucleotide linking reagents
GR3022052T3 (en) Dna sequences which code for virulence characteristics of --(streptococcus suis) and parts thereof, polypeptides and antibodies derived therefrom and the use thereof for the diagnosis of and protection against infection by --(s. suis) in mammals, including man
ZA9110087B (en) Diagnosis for porcine malignant hyperthermia
IL106894A0 (en) Dorsal tissue affecting factor and compositions
MX9708426A (es) Polipeptido hk2 de variante estable.
GB9526178D0 (en) Novel polynuceotides and polypeptides in pathogenic mycobacteria and their use as diagnostics,vaccines and targets for chemotherapy
IL122606A (en) (S)-hydroxa-nitrile-lyase
WO1992013078A3 (fr) Gene pour la glycoprotease pasteurella haemolytica et son enzyme purifiee
EP0816504A3 (fr) Facteur d'activation des plaquettes acétylhydrolase, et gène codant celui-ci
BG101787A (en) Aprotinine options having improved properties
AU3384495A (en) Or-1 on orphan receptor belonging to the nuclear receptor family
AU3929589A (en) Human papilloma virus type 57, the dna thereof and the proteins encoded thereby
GB9203821D0 (en) Improvements in or relating to malaria vaccine
AU2043597A (en) Human taki dna encoding the same
AU4174596A (en) Peptides endowed with antiinflammatory activity
ES2013025A6 (es) Un metodo para preparar 24r-escimnol.
GB2325466A (en) Nucleotide sequence from goat liver

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry